Beta Drugs Limited — Others, 29-03-2025: Trading Window

Beta Drugs Ltd. has announced a board meeting on 1st April, 2025, to discuss the audited financial results for the year ended 31st March, 2025. The trading window will be closed for all directors, officers, and designated employees from 1st April until 48 hours after the results are declared. This move is in line with the company's Code for Prevention of Insider Trading.

The closure of the trading window might instill caution among investors in the short term, but the company's focus on maintaining compliance could signal a commitment to governance. This could foster a positive outlook for shareholders when results are eventually released, offering transparency in operations.